Call Name: Mafan The Trouble
Location: Canada (CA)
Born: 2015 Jan 13 (9 Years 4 Months ago)
| Genotypes (Gene Name) | Category | Simple Value |
|---|---|---|
| MDR1 Drug Sensitivity (ABCB1) (MDR1) | clear | |
| P2Y12 Receptor Platelet Disorder (P2Y12) (P2Y12) | clear | |
| Factor IX Deficiency, Hemophilia B (F9 Exon 7, Terrier Variant) (F9 Exon 7 Variant 1) | clear | |
| Factor IX Deficiency, Hemophilia B (F9 Exon 7, Rhodesian Ridgeback Variant) (F9 Exon 7 Variant 2) | clear | |
| Factor VII Deficiency (F7 Exon 5) () | clear | |
| Factor VIII Deficiency, Hemophilia A (F8 Exon 10, Boxer Variant) () | clear | |
| Thrombopathia (RASGRP1 Exon 5, Basset Hound Variant) () | clear | |
| Thrombopathia (RASGRP1 Exon 5, American Eskimo Dog Variant) () | clear | |
| Congenital Macrothrombocytopenia (TUBB1 Exon 1, Cairn and Norfolk Terrier Variant) () | clear | |
| Canine Elliptocytosis (SPTB Exon 30) () | clear | |
| May-Hegglin Anomaly (MYH9) () | clear | |
| Prekallikrein Deficiency (KLKB1 Exon 8) () | clear | |
| Ligneous Membranitis, LM (PLG) () | clear | |
| Congenital Hypothyroidism (TPO, Tenterfield Terrier Variant) () | clear | |
| Complement 3 Deficiency, C3 Deficiency (C3) () | clear | |
| Progressive Retinal Atrophy, rcd3 (PDE6A) () | clear | |
| Progressive Retinal Atrophy, CNGA (CNGA1 Exon 9) () | clear | |
| Progressive Retinal Atrophy, prcd (PRCD Exon 1) () | clear | |
| Progressive Retinal Atrophy (SAG) () | clear | |
| Golden Retriever Progressive Retinal Atrophy 1, GR-PRA1 (SLC4A3) () | clear | |
| Golden Retriever Progressive Retinal Atrophy 2, GR-PRA2 (TTC8) () | clear | |
| Progressive Retinal Atrophy, crd2 (IQCB1) () | clear | |
| X-Linked Progressive Retinal Atrophy 1, XL-PRA1 (RPGR) () | clear | |
| Progressive Retinal Atrophy, PRA3 (FAM161A) () | clear | |
| Collie Eye Anomaly, Choroidal Hypoplasia, CEA (NHEJ1) () | clear | |
| Autosomal Dominant Progressive Retinal Atrophy (RHO) () | clear | |
| Primary Lens Luxation (ADAMTS17) () | clear | |
| Macular Corneal Dystrophy, MCD (CHST6) () | clear | |
| 2,8-Dihydroxyadenine Urolithiasis, 2,8-DHA Urolithiasis (APRT) () | clear | |
| Hyperuricosuria and Hyperuricemia or Urolithiasis, HUU (SLC2A9) () | clear | |
| Polycystic Kidney Disease, PKD (PKD1) () | clear | |
| Primary Hyperoxaluria (AGXT) () | clear | |
| Protein Losing Nephropathy, PLN (NPHS1) () | clear | |
| X-Linked Hereditary Nephropathy, XLHN (COL4A5 Exon 35, Samoyed Variant 2) () | clear | |
| Congenital Keratoconjunctivitis Sicca and Ichthyosiform Dermatosis, Dry Eye Curly Coat Syndrome, CKCSID (FAM83H Exon 5) () | clear | |
| Renal Cystadenocarcinoma and Nodular Dermatofibrosis, RCND (FLCN Exon 7) () | clear | |
| Canine Fucosidosis (FUCA1) () | clear | |
| Lagotto Storage Disease (ATG4D) () | clear | |
| GM2 Gangliosidosis (HEXB, Poodle Variant) () | clear | |
| Persistent Mullerian Duct Syndrome, PMDS (AMHR2) () | clear | |
| Deafness and Vestibular Syndrome of Dobermans, DVDob, DINGS (MYO7A) () | clear | |
| Shar-Pei Autoinflammatory Disease, SPAID, Shar-Pei Fever (MTBP) () | clear | |
| Alaskan Husky Encephalopathy, Subacute Necrotizing Encephalomyelopathy (SLC19A3) () | clear | |
| Alexander Disease (GFAP) () | clear | |
| Spinocerebellar Ataxia, Late-Onset Ataxia, LoSCA (CAPN1) () | clear | |
| Spinocerebellar Ataxia with Myokymia and/or Seizures (KCNJ10) () | clear | |
| Benign Familial Juvenile Epilepsy, Remitting Focal Epilepsy (LGI2) () | clear | |
| Degenerative Myelopathy, DM (SOD1A) () | clear | |
| Neonatal Encephalopathy with Seizures, NEWS (ATF2) () | clear | |
| Juvenile Laryngeal Paralysis and Polyneuropathy, Polyneuropathy with Ocular Abnormalities and Neuronal Vacuolation, POANV (RAB3GAP1, Rottweiler Variant) () | clear | |
| Juvenile-Onset Polyneuropathy, Leonberger Polyneuropathy 1, LPN1 (LPN1, ARHGEF10) () | clear | |
| Juvenile Myoclonic Epilepsy (DIRAS1) () | clear | |
| Juvenile-Onset Polyneuropathy, Leonberger Polyneuropathy 2, LPN2 (GJA9) () | clear | |
| Spongy Degeneration with Cerebellar Ataxia 1, SDCA1, SeSAME/EAST Syndrome (KCNJ10) () | clear | |
| Spongy Degeneration with Cerebellar Ataxia 2, SDCA2 (ATP1B2) () | clear | |
| Long QT Syndrome (KCNQ1) () | clear | |
| Muscular Dystrophy (DMD, Cavalier King Charles Spaniel Variant 1) () | clear | |
| Limb Girdle Muscular Dystrophy (SGCD, Boston Terrier Variant) () | clear | |
| Centronuclear Myopathy (PTPLA) () | clear | |
| Exercise-Induced Collapse (DNM1) () | clear | |
| Inherited Myopathy of Great Danes (BIN1) () | clear | |
| Myostatin Deficiency, Bully Whippet Syndrome (MSTN) () | clear | |
| Hypocatalasia, Acatalasemia (CAT) () | clear | |
| Malignant Hyperthermia (RYR1) () | clear | |
| Episodic Falling Syndrome (BCAN) () | clear | |
| Paroxysmal Dyskinesia, PxD (PGIN) () | clear | |
| Hereditary Vitamin D-Resistant Rickets (VDR) () | clear | |
| Craniomandibular Osteopathy, CMO (SLC37A2) () | clear | |
| Chondrodystrophy and Intervertebral Disc Disease, CDDY/IVDD, Type I IVDD (FGF4 retrogene - CFA12) () | clear | |
| E Locus (MC1R) () | EmE | |
| K Locus (CBD103) () | KyKy | |
| Intensity Loci () | Intermediate | |
| A Locus (ASIP) () | AtAt | |
| B Locus (TYRP1) () | bb | |
| M Locus (PMEL) () | mm | |
| H Locus (Harlequin) () | hh | |
| Furnishings (RSPO2) () | II | |
| Coat Length (FGF5) () | GG | |
| Shedding (MC5R) () | TT | |
| Hairlessness (FOXI3) () | N/N | |
| Hairlessness (SGK3) () | NN | |
| Oculocutaneous Albinism Type 2 (SLC45A2) () | N/N | |
| Muzzle Length (BMP3) () | CC | |
| Tail Length (T) () | CC | |
| Hind Dewclaws (LMBR1) () | CC | |
| Blue Eye Color (ALX4) () | N/N | |
| Back Muscling & Bulk, Large Breed (ACSL4) () | CC | |
| Body Size (IGF1) () | NN | |
| Body Size (IGFR1) () | GG | |
| Body Size (STC2) () | TT | |
| Body Size (GHR - E191K) () | GG | |
| Body Size (GHR - P177L) () | CC | |
| Altitude Adaptation (EPAS1) () | GG | |
| Coat Texture (KRT71) () | CC | |
| Appetite (POMC) () | N/N | |
| Factor VIII Deficiency, Hemophilia A (F8 Exon 11, German Shepherd Variant 1) () | clear | |
| Factor VIII Deficiency, Hemophilia A (F8 Exon 1, German Shepherd Variant 2) () | clear | |
| Thrombopathia (RASGRP1 Exon 8, Landseer Variant) () | clear | |
| Von Willebrand Disease Type III, Type III vWD (VWF Exon 4, Terrier Variant) () | clear | |
| Von Willebrand Disease Type III, Type III vWD (VWF Exon 7, Shetland Sheepdog Variant) () | clear | |
| Canine Leukocyte Adhesion Deficiency Type I, CLADI (ITGB2, Setter Variant) () | clear | |
| Canine Leukocyte Adhesion Deficiency Type III, CLADIII (FERMT3, German Shepherd Variant) () | clear | |
| Glanzmann's Thrombasthenia Type I (ITGA2B Exon 12, Otterhound Variant) () | clear | |
| Pyruvate Kinase Deficiency (PKLR Exon 5, Basenji Variant) () | clear | |
| Pyruvate Kinase Deficiency (PKLR Exon 7, Labrador Retriever Variant) () | clear | |
| Pyruvate Kinase Deficiency (PKLR Exon 7, Pug Variant) () | clear | |
| Pyruvate Kinase Deficiency (PKLR Exon 7, Beagle Variant) () | clear | |
| Pyruvate Kinase Deficiency (PKLR Exon 10, Terrier Variant) () | clear | |
| Trapped Neutrophil Syndrome, TNS (VPS13B) () | clear | |
| Severe Combined Immunodeficiency, SCID (PRKDC, Terrier Variant) () | clear | |
| Severe Combined Immunodeficiency, SCID (RAG1, Wetterhoun Variant) () | clear | |
| X-linked Severe Combined Immunodeficiency, X-SCID (IL2RG Exon 1, Basset Hound Variant) () | clear | |
| X-linked Severe Combined Immunodeficiency, X-SCID (IL2RG, Corgi Variant) () | clear | |
| Progressive Retinal Atrophy, rcd1 (PDE6B Exon 21, Irish Setter Variant) () | clear | |
| Progressive Retinal Atrophy, PRA1 (CNGB1) () | clear | |
| Progressive Retinal Atrophy, crd1 (PDE6B, American Staffordshire Terrier Variant) () | clear | |
| Progressive Retinal Atrophy, crd4/cord1 (RPGRIP1) () | clear | |
| Day blindness, Cone Degeneration, Achromatopsia (CNGB3 Exon 6, German Shorthaired Pointer Variant) () | clear | |
| Achromatopsia (CNGA3 Exon 7, German Shepherd Variant) () | clear | |
| Achromatopsia (CNGA3 Exon 7, Labrador Retriever Variant) () | clear | |
| Canine Multifocal Retinopathy, cmr1 (BEST1 Exon 2) () | clear | |
| Canine Multifocal Retinopathy, cmr2 (BEST1 Exon 5, Coton de Tulear Variant) () | clear | |
| Canine Multifocal Retinopathy, cmr3 (BEST1 Exon 10 Deletion, Finnish and Swedish Lapphund, Lapponian Herder Variant) () | clear | |
| Primary Open Angle Glaucoma (ADAMTS10 Exon 9, Norwegian Elkhound Variant) () | clear | |
| Primary Open Angle Glaucoma (ADAMTS10 Exon 17, Beagle Variant) () | clear | |
| Primary Open Angle Glaucoma (ADAMTS17 Exon 11, Basset Fauve de Bretagne Variant) () | clear | |
| Primary Open Angle Glaucoma and Primary Lens Luxation (ADAMTS17 Exon 2, Chinese Shar-Pei Variant) () | clear | |
| Hereditary Cataracts, Early-Onset Cataracts, Juvenile Cataracts (HSF4 Exon 9, Australian Shepherd Variant) () | clear | |
| Congenital Stationary Night Blindness (RPE65, Briard Variant) () | clear | |
| Cystinuria Type I-A (SLC3A1, Newfoundland Variant) () | clear | |
| Cystinuria Type II-A (SLC3A1, Australian Cattle Dog Variant) () | clear | |
| Cystinuria Type II-B (SLC7A9, Miniature Pinscher Variant) () | clear | |
| Autosomal Recessive Hereditary Nephropathy, Familial Nephropathy, ARHN (COL4A4 Exon 3, Cocker Spaniel Variant) () | clear | |
| Primary Ciliary Dyskinesia, PCD (CCDC39 Exon 3, Old English Sheepdog Variant) () | clear | |
| X-linked Ectodermal Dysplasia, Anhidrotic Ectodermal Dysplasia, XHED (EDA Intron 8) () | clear | |
| Glycogen Storage Disease Type II, Pompe's Disease, GSD II (GAA, Finnish and Swedish Lapphund, Lapponian Herder Variant) () | clear | |
| Glycogen Storage Disease Type IA, Von Gierke Disease, GSD IA (G6PC, Maltese Variant) () | clear | |
| Glycogen Storage Disease Type IIIA, GSD IIIA (AGL, Curly Coated Retriever Variant) () | clear | |
| Mucopolysaccharidosis Type I, MPS I (IDUA, Plott Hound Variant) () | clear | |
| Mucopolysaccharidosis Type IIIA, Sanfilippo Syndrome Type A, MPS IIIA (SGSH Exon 6, Dachshund Variant) () | clear | |
| Mucopolysaccharidosis Type IIIA, Sanfilippo Syndrome Type A, MPS IIIA (SGSH Exon 6, New Zealand Huntaway Variant) () | clear | |
| Mucopolysaccharidosis Type VII, Sly Syndrome, MPS VII (GUSB Exon 5, Terrier Brasileiro Variant) () | clear | |
| Mucopolysaccharidosis Type VII, Sly Syndrome, MPS VII (GUSB Exon 3, German Shepherd Variant) () | clear | |
| Glycogen storage disease Type VII, Phosphofructokinase Deficiency, PFK Deficiency (PFKM, Whippet and English Springer Spaniel Variant) () | clear | |
| Glycogen storage disease Type VII, Phosphofructokinase Deficiency, PFK Deficiency (PFKM, Wachtelhund Variant) () | clear | |
| Neuronal Ceroid Lipofuscinosis 1, NCL 1 (PPT1 Exon 8, Dachshund Variant 1) () | clear | |
| Neuronal Ceroid Lipofuscinosis 2, NCL 2 (TPP1 Exon 4, Dachshund Variant 2) () | clear | |
| Neuronal Ceroid Lipofuscinosis, Cerebellar Ataxia, NCL4A (ARSG Exon 2, American Staffordshire Terrier Variant) () | clear | |
| Neuronal Ceroid Lipofuscinosis 5, NCL 5 (CLN5 Exon 4 SNP, Border Collie Variant) () | clear | |
| Neuronal Ceroid Lipofuscinosis 6, NCL 6 (CLN6 Exon 7, Australian Shepherd Variant) () | clear | |
| Neuronal Ceroid Lipofuscinosis 8, NCL 8 (CLN8 Exon 2, English Setter Variant) () | clear | |
| Neuronal Ceroid Lipofuscinosis 7, NCL 7 (MFSD8, Chihuahua and Chinese Crested Variant) () | clear | |
| Neuronal Ceroid Lipofuscinosis 8, NCL 8 (CLN8, Australian Shepherd Variant) () | clear | |
| Neuronal Ceroid Lipofuscinosis 10, NCL 10 (CTSD Exon 5, American Bulldog Variant) () | clear | |
| Neuronal Ceroid Lipofuscinosis 5, NCL 5 (CLN5 Exon 4 Deletion, Golden Retriever Variant) () | clear | |
| Adult-Onset Neuronal Ceroid Lipofuscinosis, NCL A, NCL 12 (ATP13A2, Tibetan Terrier Variant) () | clear | |
| GM1 Gangliosidosis (GLB1 Exon 15, Shiba Inu Variant) () | clear | |
| GM1 Gangliosidosis (GLB1 Exon 15, Alaskan Husky Variant) () | clear | |
| GM1 Gangliosidosis (GLB1 Exon 2, Portuguese Water Dog Variant) () | clear | |
| GM2 Gangliosidosis (HEXA, Japanese Chin Variant) () | clear | |
| Globoid Cell Leukodystrophy, Krabbe disease (GALC Exon 5, Terrier Variant) () | clear | |
| Autosomal Recessive Amelogenesis Imperfecta, Familial Enamel Hypoplasia (ENAM Deletion, Italian Greyhound Variant) () | clear | |
| Cerebellar Abiotrophy, Neonatal Cerebellar Cortical Degeneration, NCCD (SPTBN2, Beagle Variant) () | clear | |
| Cerebellar Ataxia, Progressive Early-Onset Cerebellar Ataxia (SEL1L, Finnish Hound Variant) () | clear | |
| Cerebellar Hypoplasia (VLDLR, Eurasier Variant) () | clear | |
| Hereditary Ataxia, Cerebellar Degeneration (RAB24, Old English Sheepdog and Gordon Setter Variant) () | clear | |
| Fetal-Onset Neonatal Neuroaxonal Dystrophy (MFN2, Giant Schnauzer Variant) () | clear | |
| Hypomyelination and Tremors (FNIP2, Weimaraner Variant) () | clear | |
| Shaking Puppy Syndrome, X-linked Generalized Tremor Syndrome (PLP, English Springer Spaniel Variant) () | clear | |
| Neuroaxonal Dystrophy, NAD (TECPR2, Spanish Water Dog Variant) () | clear | |
| L-2-Hydroxyglutaricaciduria, L2HGA (L2HGDH, Staffordshire Bull Terrier Variant) () | clear | |
| Polyneuropathy (NDRG1 Deletion, Greyhound Variant) () | clear | |
| Polyneuropathy, AMPN (NDRG1 SNP, Alaskan Malamute Variant) () | clear | |
| Narcolepsy (HCRTR2 Intron 6, Labrador Retriever Variant) () | clear | |
| Narcolepsy (HCRTR2 Exon 1, Dachshund Variant) () | clear | |
| Progressive Neuronal Abiotrophy, Canine Multiple System Degeneration, CMSD (SERAC1 Exon 15, Kerry Blue Terrier Variant) () | clear | |
| Progressive Neuronal Abiotrophy, Canine Multiple System Degeneration, CMSD (SERAC1 Exon 4, Chinese Crested Variant) () | clear | |
| Hereditary Sensory Autonomic Neuropathy, Acral Mutilation Syndrome, AMS (GDNF-AS, Spaniel and Pointer Variant) () | clear | |
| Muscular Dystrophy (DMD, Golden Retriever Variant) () | clear | |
| Myotonia Congenita (CLCN1 Exon 7, Miniature Schnauzer Variant) () | clear | |
| Myotonia Congenita (CLCN1 Exon 23, Australian Cattle Dog Variant) () | clear | |
| Myotubular Myopathy 1, X-linked Myotubular Myopathy, XL-MTM (MTM1, Labrador Retriever Variant) () | clear | |
| Pyruvate Dehydrogenase Deficiency (PDP1, Spaniel Variant) () | clear | |
| Imerslund-Grasbeck Syndrome, Selective Cobalamin Malabsorption (CUBN Exon 53, Border Collie Variant) () | clear | |
| Imerslund-Grasbeck Syndrome, Selective Cobalamin Malabsorption (CUBN Exon 8, Beagle Variant) () | clear | |
| Congenital Myasthenic Syndrome, CMS (CHAT, Old Danish Pointing Dog Variant) () | clear | |
| Congenital Myasthenic Syndrome, CMS (COLQ, Labrador Retriever Variant) () | clear | |
| Dystrophic Epidermolysis Bullosa (COL7A1, Golden Retriever Variant) () | clear | |
| Ectodermal Dysplasia, Skin Fragility Syndrome (PKP1, Chesapeake Bay Retriever Variant) () | clear | |
| Ichthyosis, Epidermolytic Hyperkeratosis (KRT10, Terrier Variant) () | clear | |
| Ichthyosis, ICH1 (PNPLA1, Golden Retriever Variant) () | clear | |
| Ichthyosis (SLC27A4, Great Dane Variant) () | clear | |
| Ichthyosis (NIPAL4, American Bulldog Variant) () | clear | |
| Hereditary Footpad Hyperkeratosis (FAM83G, Terrier and Kromfohrlander Variant) () | clear | |
| Hereditary Nasal Parakeratosis, HNPK (SUV39H2) () | clear | |
| Musladin-Lueke Syndrome, MLS (ADAMTSL2) () | clear | |
| Oculocutaneous Albinism, OCA (SLC45A2, Pekingese Variant) () | clear | |
| Cleft Lip and/or Cleft Palate (ADAMTS20, Nova Scotia Duck Tolling Retriever Variant) () | clear | |
| Osteogenesis Imperfecta, Brittle Bone Disease (COL1A2, Beagle Variant) () | clear | |
| Osteogenesis Imperfecta, Brittle Bone Disease (SERPINH1, Dachshund Variant) () | clear | |
| Osteogenesis Imperfecta, Brittle Bone Disease (COL1A1, Golden Retriever Variant) () | clear | |
| Osteochondrodysplasia, Skeletal Dwarfism (SLC13A1, Poodle Variant) () | clear | |
| Skeletal Dysplasia 2, SD2 (COL11A2, Labrador Retriever Variant) () | clear | |
| Chondrodystrophy (ITGA10, Norwegian Elkhound and Karelian Bear Dog Variant) () | clear | |
| D Locus (MLPH) () | DD | |
| Saddle Tan (RALY) () | II | |
| Predicted Adult Weight () | 64.00 lbs | |
| MT Haplotype () | A226_MT | |
| MT Haplogroup () | A1e_MT | |
| Y Haplotype () | ||
| Y Haplogroup () | ||
| Alanine Aminotransferase Activity (GPT) (GPT) | at risk, heterozygote codominant | |
| Von Willebrand Disease Type I, Type I vWD (VWF) () | carrier, heterozygote recessive | |
| Dilated Cardiomyopathy, DCM1 (PDK4, Doberman Pinscher Variant 1) () | at risk, homozygote dominant | |
| Dilated Cardiomyopathy, DCM2 (TTN, Doberman Pinscher Variant 2) () | at risk, homozygote dominant | |
| Coefficient Of Inbreeding () | 0.315135 | |
| MHC Class II - DLA DRB1 () | 2 | |
| MHC Class II - DLA DQA1 and DQB1 () | 2 | |
| S Locus (MITF) () | spsp |